TY - JOUR AU - Booth, G. L. AU - Kapral, M. K. AU - Fung, K. AU - Tu, J. V. PY - 2006 DA - 2006// TI - Recent trends in cardiovascular complications among men and women with and without diabetes JO - Diabetes Care VL - 29 UR - https://doi.org/10.2337/diacare.29.01.06.dc05-0776 DO - 10.2337/diacare.29.01.06.dc05-0776 ID - Booth2006 ER - TY - JOUR AU - Haffner, S. J. AU - Cassells, H. PY - 2003 DA - 2003// TI - Hyperglycemia as a cardiovascular risk factor JO - Am J Med VL - 115 UR - https://doi.org/10.1016/j.amjmed.2003.09.009 DO - 10.1016/j.amjmed.2003.09.009 ID - Haffner2003 ER - TY - JOUR AU - Haffner, S. M. AU - Lehto, S. AU - Rönnemaa, T. AU - Pyörälä, K. AU - Laakso, M. PY - 1998 DA - 1998// TI - Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199807233390404 DO - 10.1056/NEJM199807233390404 ID - Haffner1998 ER - TY - JOUR AU - Grundy, S. M. AU - Benjamin, I. J. AU - Burke, G. L. AU - Chait, A. AU - Eckel, R. H. AU - Howard, B. V. AU - Mitch, W. AU - Smith, S. C. AU - Sowers, J. R. PY - 1999 DA - 1999// TI - Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association JO - Circulation VL - 100 UR - https://doi.org/10.1161/01.CIR.100.10.1134 DO - 10.1161/01.CIR.100.10.1134 ID - Grundy1999 ER - TY - JOUR AU - Perk, J. AU - De Backer, G. AU - Gohlke, H. AU - Graham, I. AU - Reiner, Z. AU - Verschuren, W. M. AU - Albus, C. AU - Benlian, P. AU - Boysen, G. AU - Cifkova, R. AU - Deaton, C. AU - Ebrahim, S. AU - Fisher, M. AU - Germano, G. AU - Hobbs, R. AU - Hoes, A. AU - Karadeniz, S. AU - Mezzani, A. AU - Prescott, E. AU - Ryden, L. AU - Scherer, M. AU - Syvänne, M. AU - Scholte Op Reimer, W. J. AU - Vrints, C. AU - Wood, D. AU - Zamorano, J. L. AU - Zannad, F. PY - 2012 DA - 2012// TI - European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) JO - Atherosclerosis VL - 223 UR - https://doi.org/10.1016/j.atherosclerosis.2012.05.007 DO - 10.1016/j.atherosclerosis.2012.05.007 ID - Perk2012 ER - TY - JOUR AU - McIntyre, N. AU - Holsworth, D. C. AU - Turner, D. S. PY - 1964 DA - 1964// TI - New interpretation of oral glucose tolerance JO - Lancet VL - 2 UR - https://doi.org/10.1016/S0140-6736(64)90011-X DO - 10.1016/S0140-6736(64)90011-X ID - McIntyre1964 ER - TY - JOUR AU - Creutzfeldt, W. AU - Ebert, R. PY - 1985 DA - 1985// TI - New developments in the incretin concept JO - Diabetologia VL - 28 UR - https://doi.org/10.1007/BF00281990 DO - 10.1007/BF00281990 ID - Creutzfeldt1985 ER - TY - JOUR AU - Nauck, M. AU - Stockmann, F. AU - Ebert, R. AU - Creutzfeldt, W. PY - 1986 DA - 1986// TI - Reduced incretin effect in type 2 (non-insulin-dependent) diabetes JO - Diabetologia VL - 29 UR - https://doi.org/10.1007/BF02427280 DO - 10.1007/BF02427280 ID - Nauck1986 ER - TY - JOUR AU - An, Z. AU - Prigeon, R. L. AU - D’Alessio, D. A. PY - 2013 DA - 2013// TI - Improved glycemic control enhances the incretin effect in patients with type 2 diabetes JO - J Clin Endocrinol Metab VL - 98 UR - https://doi.org/10.1210/jc.2013-1199 DO - 10.1210/jc.2013-1199 ID - An2013 ER - TY - JOUR AU - Kieffer, T. J. AU - Habener, J. F. PY - 1999 DA - 1999// TI - The glucagon-like peptides JO - Endocr Rev VL - 20 UR - https://doi.org/10.1210/edrv.20.6.0385 DO - 10.1210/edrv.20.6.0385 ID - Kieffer1999 ER - TY - JOUR AU - Wei, Y. AU - Mojsov, S. PY - 1995 DA - 1995// TI - Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences JO - FEBS Lett VL - 358 UR - https://doi.org/10.1016/0014-5793(94)01430-9 DO - 10.1016/0014-5793(94)01430-9 ID - Wei1995 ER - TY - JOUR AU - Körner, M. AU - Stöckli, M. AU - Waser, B. AU - Reubi, J. C. PY - 2007 DA - 2007// TI - GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting JO - J Nucl Med VL - 48 UR - https://doi.org/10.2967/jnumed.106.038679 DO - 10.2967/jnumed.106.038679 ID - Körner2007 ER - TY - JOUR AU - Lund, A. AU - Knop, F. K. AU - Vilsbøll, T. PY - 2014 DA - 2014// TI - Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities JO - Eur J Intern Med VL - 25 UR - https://doi.org/10.1016/j.ejim.2014.03.005 DO - 10.1016/j.ejim.2014.03.005 ID - Lund2014 ER - TY - JOUR AU - Baggio, L. L. AU - Drucker, D. J. PY - 2007 DA - 2007// TI - Biology of incretins: GLP-1 and GIP JO - Gastroenterology VL - 132 UR - https://doi.org/10.1053/j.gastro.2007.03.054 DO - 10.1053/j.gastro.2007.03.054 ID - Baggio2007 ER - TY - JOUR AU - Godoy-Matos, A. F. PY - 2014 DA - 2014// TI - The role of glucagon on type 2 diabetes at a glance JO - Diabetol Metab Syndr VL - 6 UR - https://doi.org/10.1186/1758-5996-6-91 DO - 10.1186/1758-5996-6-91 ID - Godoy-Matos2014 ER - TY - JOUR AU - De Marinis, Y. Z. AU - Salehi, A. AU - Ward, C. E. AU - Zhang, Q. AU - Abdulkader, F. AU - Bengtsson, M. AU - Braha, O. AU - Braun, M. AU - Ramracheya, R. AU - Amisten, S. AU - Habib, A. M. AU - Moritoh, Y. AU - Zang, E. AU - Reimann, F. AU - Rosengren, A. H. AU - Shibasaki, T. AU - Gribble, F. AU - Renström, E. AU - Seino, S. AU - Eliasson, L. AU - Rorsman, P. PY - 2010 DA - 2010// TI - GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis JO - Cell Metab VL - 11 UR - https://doi.org/10.1016/j.cmet.2010.04.007 DO - 10.1016/j.cmet.2010.04.007 ID - De Marinis2010 ER - TY - JOUR AU - De Heer, J. AU - Rasmussen, C. AU - Coy, D. H. AU - Holst, J. J. PY - 2008 DA - 2008// TI - Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas JO - Diabetologia VL - 51 UR - https://doi.org/10.1007/s00125-008-1149-y DO - 10.1007/s00125-008-1149-y ID - De Heer2008 ER - TY - JOUR AU - Little, T. J. AU - Pilichiewicz, A. N. AU - Russo, A. AU - Phillips, L. AU - Jones, K. L. AU - Nauck, M. A. AU - Wishart, J. AU - Horowitz, M. AU - Feinle-Bisset, C. PY - 2006 DA - 2006// TI - Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses JO - J Clin Endocrinol Metab VL - 91 UR - https://doi.org/10.1210/jc.2005-2220 DO - 10.1210/jc.2005-2220 ID - Little2006 ER - TY - JOUR AU - Flint, A. AU - Raben, A. AU - Astrup, A. AU - Holst, J. J. PY - 1998 DA - 1998// TI - Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans JO - J Clin Invest VL - 101 UR - https://doi.org/10.1172/JCI990 DO - 10.1172/JCI990 ID - Flint1998 ER - TY - JOUR AU - Dailey, M. J. AU - Moran, T. H. PY - 2013 DA - 2013// TI - Glucagon-like peptide 1 and appetite JO - Trends Endocrinol Metab VL - 24 UR - https://doi.org/10.1016/j.tem.2012.11.008 DO - 10.1016/j.tem.2012.11.008 ID - Dailey2013 ER - TY - JOUR AU - Ørskov, C. AU - Poulsen, S. S. AU - Møller, M. AU - Holst, J. J. PY - 1996 DA - 1996// TI - Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I JO - Diabetes VL - 45 UR - https://doi.org/10.2337/diab.45.6.832 DO - 10.2337/diab.45.6.832 ID - Ørskov1996 ER - TY - JOUR AU - Pannacciulli, N. AU - Bunt, J. C. AU - Koska, J. AU - Bogardus, C. AU - Krakoff, J. PY - 2006 DA - 2006// TI - Higher fasting plasma concentrations of glucagon-like peptide 1 are associated with higher resting energy expenditure and fat oxidation rates in humans JO - Am J Clin Nutr VL - 84 ID - Pannacciulli2006 ER - TY - JOUR AU - Komatsu, M. AU - Takei, M. AU - Ishii, H. AU - Sato, Y. PY - 2013 DA - 2013// TI - Glucose-stimulated insulin secretion: a newer perspective JO - J Diabetes Investig VL - 4 UR - https://doi.org/10.1111/jdi.12094 DO - 10.1111/jdi.12094 ID - Komatsu2013 ER - TY - JOUR AU - Sussman, M. A. AU - Völkers, M. AU - Fischer, K. AU - Bailey, B. AU - Cottage, C. T. AU - Din, S. AU - Gude, N. AU - Avitabile, D. AU - Alvarez, R. AU - Sundararaman, B. AU - Quijada, P. AU - Mason, M. AU - Konstandin, M. H. AU - Malhowski, A. AU - Cheng, Z. AU - Khan, M. AU - McGregor, M. PY - 2011 DA - 2011// TI - Myocardial AKT: the omnipresent nexus JO - Physiol Rev VL - 91 UR - https://doi.org/10.1152/physrev.00024.2010 DO - 10.1152/physrev.00024.2010 ID - Sussman2011 ER - TY - JOUR AU - Cornu, M. AU - Modi, H. AU - Kawamori, D. AU - Kulkarni, R. N. AU - Joffraud, M. AU - Thorens, B. PY - 2010 DA - 2010// TI - Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression JO - J Biol Chem VL - 285 UR - https://doi.org/10.1074/jbc.M109.091116 DO - 10.1074/jbc.M109.091116 ID - Cornu2010 ER - TY - JOUR AU - Aroor, A. R. AU - Sowers, J. R. AU - Jia, G. AU - DeMarco, V. G. PY - 2014 DA - 2014// TI - Pleiotropic Effects of the Dipeptidylpeptidase-4 Inhibitors on the Cardiovascular System JO - Am J Physiol Heart Circ Physiol VL - 307 UR - https://doi.org/10.1152/ajpheart.00209.2014 DO - 10.1152/ajpheart.00209.2014 ID - Aroor2014 ER - TY - JOUR AU - Scirica, B. M. AU - Bhatt, D. L. AU - Braunwald, E. AU - Steg, P. G. AU - Davidson, J. AU - Hirshberg, B. AU - Ohman, P. AU - Frederich, R. AU - Wiviott, S. D. AU - Hoffman, E. B. AU - Cavender, M. A. AU - Udell, J. A. AU - Desai, N. R. AU - Mosenzon, O. AU - McGuire, D. K. AU - Ray, K. K. AU - Leiter, L. A. AU - Raz, I. PY - 2013 DA - 2013// TI - SAVOR-TIMI 53 Steering Committee and Investigators. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1307684 DO - 10.1056/NEJMoa1307684 ID - Scirica2013 ER - TY - JOUR AU - White, W. B. AU - Cannon, C. P. AU - Heller, S. R. AU - Nissen, S. E. AU - Bergenstal, R. M. AU - Bakris, G. L. AU - Perez, A. T. AU - Fleck, P. R. AU - Mehta, C. R. AU - Kupfer, S. AU - Wilson, C. AU - Cushman, W. C. AU - Zannad, F. PY - 2013 DA - 2013// TI - EXAMINE Investigators. Alogliptin after acute coronary syndrome in patients with type 2 diabetes JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMoa1305889 DO - 10.1056/NEJMoa1305889 ID - White2013 ER - TY - JOUR AU - Gupta, V. PY - 2012 DA - 2012// TI - Pleiotropic effects of incretins JO - Indian J Endocrinol Metab VL - 16 UR - https://doi.org/10.4103/2230-8210.94259 DO - 10.4103/2230-8210.94259 ID - Gupta2012 ER - TY - JOUR AU - Kirkpatrick, A. AU - Heo, J. AU - Abrol, R. AU - Goddard, W. A. PY - 2012 DA - 2012// TI - Predicted structure of agonist-bound glucagon-like peptide 1 receptor, a class B G protein-coupled receptor JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1218051109 DO - 10.1073/pnas.1218051109 ID - Kirkpatrick2012 ER - TY - JOUR AU - Bullock, B. P. AU - Heller, R. S. AU - Habener, J. F. PY - 1996 DA - 1996// TI - Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor JO - Endocrinology VL - 137 ID - Bullock1996 ER - TY - JOUR AU - Ban, K. AU - Kim, K. H. AU - Cho, C. K. AU - Sauvé, M. AU - Diamandis, E. P. AU - Backx, P. H. AU - Drucker, D. J. AU - Husain, M. PY - 2010 DA - 2010// TI - Glucagon-like peptide (GLP)-1(9-36)amide-mediated cytoprotection is blocked by exendin(9-39) yet does not require the known GLP-1 receptor JO - Endocrinology VL - 151 UR - https://doi.org/10.1210/en.2009-1197 DO - 10.1210/en.2009-1197 ID - Ban2010 ER - TY - JOUR AU - Nyström, T. AU - Gutniak, M. K. AU - Zhang, Q. AU - Zhang, F. AU - Holst, J. J. AU - Ahrén, B. AU - Sjöholm, A. PY - 2004 DA - 2004// TI - Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease JO - Am J Physiol Endocrinol Metab VL - 287 UR - https://doi.org/10.1152/ajpendo.00237.2004 DO - 10.1152/ajpendo.00237.2004 ID - Nyström2004 ER - TY - JOUR AU - Ishibashi, Y. AU - Matsui, T. AU - Takeuchi, M. AU - Yamagishi, S. PY - 2010 DA - 2010// TI - Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression JO - Biochem Biophys Res Commun VL - 391 UR - https://doi.org/10.1016/j.bbrc.2009.12.075 DO - 10.1016/j.bbrc.2009.12.075 ID - Ishibashi2010 ER - TY - JOUR AU - Ban, K. AU - Noyan-Ashraf, M. H. AU - Hoefer, J. AU - Bolz, S. S. AU - Drucker, D. J. AU - Husain, M. PY - 2008 DA - 2008// TI - Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and-independent pathways JO - Circulation VL - 117 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.739938 DO - 10.1161/CIRCULATIONAHA.107.739938 ID - Ban2008 ER - TY - JOUR AU - Ussher, J. R. AU - Drucker, D. J. PY - 2014 DA - 2014// TI - Cardiovascular actions of incretin-based therapies JO - Circ Res VL - 114 UR - https://doi.org/10.1161/CIRCRESAHA.114.301958 DO - 10.1161/CIRCRESAHA.114.301958 ID - Ussher2014 ER - TY - JOUR AU - Kuna, R. S. AU - Girada, S. B. AU - Asalla, S. AU - Vallentyne, J. AU - Maddika, S. AU - Patterson, J. T. AU - Smiley, D. L. AU - DiMarchi, R. D. AU - Mitra, P. PY - 2013 DA - 2013// TI - Glucagon-like peptide-1 receptor-mediated endosomal cAMP generation promotes glucose-stimulated insulin secretion in pancreatic ncreatic JO - Am J Physiol Endocrinol Metab VL - 305 UR - https://doi.org/10.1152/ajpendo.00551.2012 DO - 10.1152/ajpendo.00551.2012 ID - Kuna2013 ER - TY - JOUR AU - Vila Petroff, M. G. AU - Egan, J. M. AU - Wang, X. AU - Sollott, S. J. PY - 2001 DA - 2001// TI - Glucagon- like peptide-1 increases cAMP but fails to augment contraction in adult rat cardiac myocytes JO - Circ Res VL - 89 UR - https://doi.org/10.1161/hh1701.095716 DO - 10.1161/hh1701.095716 ID - Vila Petroff2001 ER - TY - JOUR AU - Gigoux, V. AU - Fourmy, D. PY - 2013 DA - 2013// TI - Acting on hormone receptors with minimal side effect on cell proliferation: a timely challenge illustrated with GLP-1R and GPER JO - Front Endocrinol VL - 4 UR - https://doi.org/10.3389/fendo.2013.00050 DO - 10.3389/fendo.2013.00050 ID - Gigoux2013 ER - TY - JOUR AU - Xiao, Y. F. AU - Nikolskaya, A. AU - Jaye, D. A. AU - Sigg, D. C. PY - 2011 DA - 2011// TI - Glucagon-like peptide-1 enhances cardiac L-type Ca2+ currents via activation of the cAMP-dependent protein kinase A pathway JO - Cardiovasc Diabetol VL - 10 UR - https://doi.org/10.1186/1475-2840-10-6 DO - 10.1186/1475-2840-10-6 ID - Xiao2011 ER - TY - JOUR AU - Rose, B. A. AU - Force, T. AU - Wang, Y. PY - 2010 DA - 2010// TI - Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale JO - Physiol Rev VL - 90 UR - https://doi.org/10.1152/physrev.00054.2009 DO - 10.1152/physrev.00054.2009 ID - Rose2010 ER - TY - JOUR AU - Chang, G. AU - Zhang, D. AU - Yu, H. AU - Zhang, P. AU - Wang, Y. AU - Zheng, A. AU - Qin, S. PY - 2013 DA - 2013// TI - Cardioprotective effects of exenatide against oxidative stress-induced injury JO - Int J Mol Med VL - 32 ID - Chang2013 ER - TY - JOUR AU - Shan, P. R. AU - Xu, W. W. AU - Huang, Z. Q. AU - Pu, J. AU - Huang, W. J. PY - 2014 DA - 2014// TI - Protective role of retinoid X receptor in H9c2 cardiomyocytes from hypoxia/reoxygenation injury in rats JO - World J Emerg Med VL - 5 UR - https://doi.org/10.5847/wjem.j.issn.1920-8642.2014.02.008 DO - 10.5847/wjem.j.issn.1920-8642.2014.02.008 ID - Shan2014 ER - TY - JOUR AU - Ravassa, S. AU - Zudaire, A. AU - Carr, R. D. AU - Díez, J. PY - 2011 DA - 2011// TI - Antiapoptotic effects of GLP-1 in murine HL-1 cardiomyocytes JO - Am J Physiol Heart Circ Physiol VL - 300 UR - https://doi.org/10.1152/ajpheart.00885.2010 DO - 10.1152/ajpheart.00885.2010 ID - Ravassa2011 ER - TY - JOUR AU - Nikolaidis, L. A. AU - Elahi, D. AU - Hentosz, T. AU - Doverspike, A. AU - Huerbin, R. AU - Zourelias, L. AU - Stolarski, C. AU - Shen, Y. T. AU - Shannon, R. P. PY - 2004 DA - 2004// TI - Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy JO - Circulation VL - 110 UR - https://doi.org/10.1161/01.CIR.0000139339.85840.DD DO - 10.1161/01.CIR.0000139339.85840.DD ID - Nikolaidis2004 ER - TY - JOUR AU - Moberly, S. P. AU - Mather, K. J. AU - Berwick, Z. C. AU - Owen, M. K. AU - Goodwill, A. G. AU - Casalini, E. D. AU - Hutchins, G. D. AU - Green, M. A. AU - Ng, Y. AU - Considine, R. V. AU - Perry, K. M. AU - Chisholm, R. L. AU - Tune, J. D. PY - 2013 DA - 2013// TI - Impaired cardiometabolic responses to glucagon-like peptide 1 in obesity and type 2 diabetes mellitus JO - Basic Res Cardiol VL - 108 UR - https://doi.org/10.1007/s00395-013-0365-x DO - 10.1007/s00395-013-0365-x ID - Moberly2013 ER - TY - JOUR AU - Moberly, S. P. AU - Berwick, Z. C. AU - Kohr, M. AU - Svendsen, M. AU - Mather, K. J. AU - Tune, J. D. PY - 2012 DA - 2012// TI - Intracoronary glucagon-like peptide 1 preferentially augments glucose uptake in ischemic myocardium independent of changes in coronary flow JO - Exp Biol Med VL - 237 UR - https://doi.org/10.1258/ebm.2011.011288 DO - 10.1258/ebm.2011.011288 ID - Moberly2012 ER - TY - JOUR AU - Zhao, T. C. PY - 2013 DA - 2013// TI - Glucagon-like peptide-1 (GLP-1) and protective effects in cardiovascular disease: a new therapeutic approach for myocardial protection JO - Cardiovasc Diabetol VL - 12 UR - https://doi.org/10.1186/1475-2840-12-90 DO - 10.1186/1475-2840-12-90 ID - Zhao2013 ER - TY - JOUR AU - Sokos, G. G. AU - Nikolaidis, L. A. AU - Mankad, S. AU - Elahi, D. AU - Shannon, R. P. PY - 2006 DA - 2006// TI - Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure JO - J Card Fail VL - 12 UR - https://doi.org/10.1016/j.cardfail.2006.08.211 DO - 10.1016/j.cardfail.2006.08.211 ID - Sokos2006 ER - TY - JOUR AU - Sokos, G. G. AU - Bolukoglu, H. AU - German, J. AU - Hentosz, T. AU - Magovern, G. J. AU - Maher, T. D. AU - Dean, D. A. AU - Bailey, S. H. AU - Marrone, G. AU - Benckart, D. H. AU - Elahi, D. AU - Shannon, R. P. PY - 2007 DA - 2007// TI - Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting JO - Am J Cardiol VL - 100 UR - https://doi.org/10.1016/j.amjcard.2007.05.022 DO - 10.1016/j.amjcard.2007.05.022 ID - Sokos2007 ER - TY - JOUR AU - Barragán, J. M. AU - Rodríguez, R. E. AU - Blázquez, E. PY - 1994 DA - 1994// TI - Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36 amide) in rats JO - Am J Physiol VL - 266 ID - Barragán1994 ER - TY - STD TI - Robinson LE, Holt TA, Rees K, Randeva HS, O’Hare JP: Effects of exenatide and liraglutide on heart rate, blood pressure and body weight: systematic review and meta-analysis.BMJ Open 2013, 3(1). doi:10.1136/bmjopen-2012-001986., ID - ref52 ER - TY - JOUR AU - Edwards, C. M. AU - Todd, J. F. AU - Ghatei, M. A. AU - Bloom, S. R. PY - 1998 DA - 1998// TI - Subcutaneous glucagon-like peptide-1 (7-36) amide is insulinotropic and can cause hypoglycaemia in fasted healthy subjects JO - Clin Sci VL - 95 UR - https://doi.org/10.1042/cs0950719 DO - 10.1042/cs0950719 ID - Edwards1998 ER - TY - JOUR AU - Ceriello, A. AU - Novials, A. AU - Canivell, S. AU - La Sala, L. AU - Pujadas, G. AU - Esposito, K. AU - Testa, R. AU - Bucciarelli, L. AU - Rondinelli, M. AU - Genovese, S. PY - 2014 DA - 2014// TI - Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory, and antioxidant action in type 2 diabetes JO - Diabetes Care VL - 37 UR - https://doi.org/10.2337/dc13-2618 DO - 10.2337/dc13-2618 ID - Ceriello2014 ER - TY - JOUR AU - Erdogdu, O. AU - Nathanson, D. AU - Sjöholm, A. AU - Nyström, T. AU - Zhang, Q. PY - 2010 DA - 2010// TI - Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor JO - Mol Cell Endocrinol VL - 325 UR - https://doi.org/10.1016/j.mce.2010.04.022 DO - 10.1016/j.mce.2010.04.022 ID - Erdogdu2010 ER - TY - JOUR AU - Wang, D. AU - Luo, P. AU - Wang, Y. AU - Li, W. AU - Wang, C. AU - Sun, D. AU - Zhang, R. AU - Su, T. AU - Ma, X. AU - Zeng, C. AU - Wang, H. AU - Ren, J. AU - Cao, F. PY - 2013 DA - 2013// TI - Glucagon-like peptide-1 protects against cardiac microvascular injury in diabetes via a cAMP/PKA/Rho-dependent mechanism JO - Diabetes VL - 62 UR - https://doi.org/10.2337/db12-1025 DO - 10.2337/db12-1025 ID - Wang2013 ER - TY - JOUR AU - Batchuluun, B. AU - Inoguchi, T. AU - Sonoda, N. AU - Sasaki, S. AU - Inoue, T. AU - Fujimura, Y. AU - Miura, D. AU - Takayanagi, R. PY - 2014 DA - 2014// TI - Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells JO - Atherosclerosis VL - 232 UR - https://doi.org/10.1016/j.atherosclerosis.2013.10.025 DO - 10.1016/j.atherosclerosis.2013.10.025 ID - Batchuluun2014 ER - TY - JOUR AU - Kelly, A. S. AU - Richard, M. AU - Bergenstal, R. M. AU - Gonzalez-Campoy, J. M. AU - Harold Katz, H. AU - Bank, A. J. PY - 2012 DA - 2012// TI - Effects of Exenatide vs. Metformin on endothelial function in obese patients with pre-diabetes: a randomized trial JO - Cardiovasc Diabetol VL - 11 UR - https://doi.org/10.1186/1475-2840-11-64 DO - 10.1186/1475-2840-11-64 ID - Kelly2012 ER - TY - JOUR AU - Basu, A. AU - Charkoudian, N. AU - Schrage, W. AU - Rizza, R. A. AU - Basu, R. AU - Joyner, M. J. PY - 2007 DA - 2007// TI - Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride JO - Am J Physiol Endocrinol Metab VL - 293 UR - https://doi.org/10.1152/ajpendo.00373.2007 DO - 10.1152/ajpendo.00373.2007 ID - Basu2007 ER - TY - JOUR AU - Ceriello, A. AU - Esposito, K. AU - Testa, R. AU - Bonfigli, A. R. AU - Marra, M. AU - Giugliano, D. PY - 2011 DA - 2011// TI - The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an “endothelial resistance” to glucagon-like peptide 1 in diabetes JO - Diabetes Care VL - 34 UR - https://doi.org/10.2337/dc10-1949 DO - 10.2337/dc10-1949 ID - Ceriello2011 ER - TY - JOUR AU - Gutzwiller, J. P. AU - Tschopp, S. AU - Bock, A. AU - Zehnder, C. E. AU - Huber, A. R. AU - Kreyenbuehl, M. AU - Gutmann, H. AU - Drewe, J. AU - Henzen, C. AU - Goeke, B. AU - Beglinger, C. PY - 2004 DA - 2004// TI - Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men JO - J Clin Endocrinol Metab VL - 89 UR - https://doi.org/10.1210/jc.2003-031403 DO - 10.1210/jc.2003-031403 ID - Gutzwiller2004 ER - TY - JOUR AU - Kim, M. AU - Platt, M. J. AU - Shibasaki, T. AU - Quaggin, S. E. AU - Backx, P. H. AU - Seino, S. AU - Simpson, J. A. AU - Drucker, D. J. PY - 2013 DA - 2013// TI - GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3128 DO - 10.1038/nm.3128 ID - Kim2013 ER - TY - JOUR AU - Arakawa, M. AU - Mita, T. AU - Azuma, K. AU - Ebato, C. AU - Goto, H. AU - Nomiyama, T. AU - Fujitani, Y. AU - Hirose, T. AU - Kawamori, R. AU - Watada, H. PY - 2010 DA - 2010// TI - Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4 JO - Diabetes VL - 59 UR - https://doi.org/10.2337/db09-1694 DO - 10.2337/db09-1694 ID - Arakawa2010 ER - TY - JOUR AU - Piotrowski, K. AU - Becker, M. AU - Zugwurst, J. AU - Biller-Friedmann, I. AU - Spoettl, G. AU - Greif, M. AU - Leber, A. W. AU - Becker, A. AU - Laubender, R. P. AU - Lebherz, C. AU - Goeke, B. AU - Marx, N. AU - Parhofer, K. G. AU - Lehrke, M. PY - 2013 DA - 2013// TI - Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans JO - Cardiovasc Diabetol VL - 12 UR - https://doi.org/10.1186/1475-2840-12-117 DO - 10.1186/1475-2840-12-117 ID - Piotrowski2013 ER - TY - JOUR AU - Goto, H. AU - Nomiyama, T. AU - Mita, T. AU - Yasunari, E. AU - Azuma, K. AU - Komiya, K. AU - Arakawa, M. AU - Jin, W. L. AU - Kanazawa, A. AU - Kawamori, R. AU - Fujitani, Y. AU - Hirose, T. AU - Watada, H. PY - 2011 DA - 2011// TI - Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces intimal thickening after vascular injury JO - Biochem Biophys Res Commun VL - 405 UR - https://doi.org/10.1016/j.bbrc.2010.12.131 DO - 10.1016/j.bbrc.2010.12.131 ID - Goto2011 ER - TY - JOUR AU - Nagashima, M. AU - Watanabe, T. AU - Terasaki, M. AU - Tomoyasu, M. AU - Nohtomi, K. AU - Kim-Kaneyama, J. AU - Miyazaki, A. AU - Hirano, T. PY - 2011 DA - 2011// TI - Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice JO - Diabetologia VL - 54 UR - https://doi.org/10.1007/s00125-011-2241-2 DO - 10.1007/s00125-011-2241-2 ID - Nagashima2011 ER - TY - JOUR AU - Tashiro, Y. AU - Sato, K. AU - Watanabe, T. AU - Nohtomi, K. AU - Terasaki, M. AU - Nagashima, M. AU - Hirano, T. PY - 2014 DA - 2014// TI - A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis JO - Peptides VL - S0196-9781 ID - Tashiro2014 ER - TY - JOUR AU - Liu, H. AU - Dear, A. E. AU - Knudsen, L. B. AU - Simpson, R. W. PY - 2009 DA - 2009// TI - A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules JO - J Endocrinol VL - 201 UR - https://doi.org/10.1677/JOE-08-0468 DO - 10.1677/JOE-08-0468 ID - Liu2009 ER - TY - JOUR AU - Best, J. H. AU - Hoogwerf, B. J. AU - Herman, W. H. AU - Pelletier, E. M. AU - Smith, D. B. AU - Wenten, M. AU - Hussein, M. A. PY - 2011 DA - 2011// TI - Risk of cardiovascular disease events in patients with type 2 diabetes prescribed the glucagon-like peptide 1 (GLP-1) receptor agonist exenatide twice daily or other glucose-lowering therapies: a retrospective analysis of the LifeLink database JO - Diabetes Care VL - 34 UR - https://doi.org/10.2337/dc10-1393 DO - 10.2337/dc10-1393 ID - Best2011 ER - TY - JOUR AU - Ratner, R. AU - Han, J. AU - Nicewarner, D. AU - Yushmanova, I. AU - Hoogwerf, B. J. AU - Shen, L. PY - 2011 DA - 2011// TI - Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes JO - Cardiovasc Diabetol VL - 10 UR - https://doi.org/10.1186/1475-2840-10-22 DO - 10.1186/1475-2840-10-22 ID - Ratner2011 ER - TY - JOUR AU - Nathanson, D. AU - Ullman, B. AU - Löfström, U. AU - Hedman, A. AU - Frick, M. AU - Sjöholm, A. AU - Nyström, T. PY - 2012 DA - 2012// TI - Effects of intravenous exenatide in type 2 diabetic patients with congestive heart failure: a double-blind, randomised controlled clinical trial of efficacy and safety JO - Diabetologia VL - 55 UR - https://doi.org/10.1007/s00125-011-2440-x DO - 10.1007/s00125-011-2440-x ID - Nathanson2012 ER - TY - JOUR AU - Nikolaidis, L. A. AU - Mankad, S. AU - Sokos, G. G. AU - Miske, G. AU - Shah, A. AU - Elahi, D. AU - Shannon, R. P. PY - 2004 DA - 2004// TI - Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion JO - Circulation VL - 109 UR - https://doi.org/10.1161/01.CIR.0000120505.91348.58 DO - 10.1161/01.CIR.0000120505.91348.58 ID - Nikolaidis2004 ER - TY - JOUR AU - Woo, J. S. AU - Kim, W. AU - Ha, S. J. AU - Kim, J. B. AU - Kim, S. J. AU - Kim, W. S. AU - Seon, H. J. AU - Kim, K. S. PY - 2013 DA - 2013// TI - Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study JO - Arterioscler Thromb Vasc Biol VL - 33 UR - https://doi.org/10.1161/ATVBAHA.113.301586 DO - 10.1161/ATVBAHA.113.301586 ID - Woo2013 ER - TY - JOUR AU - Hermansen, K. AU - Bækdal, T. A. AU - Düring, M. AU - Pietraszek, A. AU - Mortensen, L. S. AU - Jørgensen, H. AU - Flint, A. PY - 2013 DA - 2013// TI - Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial JO - Diab Obesity Metabol VL - 15 UR - https://doi.org/10.1111/dom.12133 DO - 10.1111/dom.12133 ID - Hermansen2013 ER - TY - JOUR AU - Meloni, A. R. AU - DeYoung, M. B. AU - Han, J. AU - Best, J. H. AU - Grimm, M. PY - 2013 DA - 2013// TI - Treatment of patients with type 2 diabetes with exenatide once weekly versus oral glucose-lowering medications or insulin glargine: achievement of glycemic and cardiovascular goals JO - Cardiovasc Diabetol VL - 12 UR - https://doi.org/10.1186/1475-2840-12-48 DO - 10.1186/1475-2840-12-48 ID - Meloni2013 ER - TY - JOUR AU - Zhao, T. AU - Parikh, P. AU - Bhashyam, S. AU - Bolukoglu, H. AU - Poornima, I. AU - Shen, Y. T. AU - Shannon, R. P. PY - 2006 DA - 2006// TI - Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts JO - J Pharmacol Exp Ther VL - 317 UR - https://doi.org/10.1124/jpet.106.100982 DO - 10.1124/jpet.106.100982 ID - Zhao2006 ER - TY - JOUR AU - Hattori, Y. AU - Jojima, T. AU - Tomizawa, A. AU - Satoh, H. AU - Hattori, S. AU - Kasai, K. AU - Hayashi, T. PY - 2010 DA - 2010// TI - A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells JO - Diabetologia VL - 53 UR - https://doi.org/10.1007/s00125-010-1831-8 DO - 10.1007/s00125-010-1831-8 ID - Hattori2010 ER - TY - JOUR AU - Read, P. A. AU - Khan, F. Z. AU - Dutka, D. P. PY - 2012 DA - 2012// TI - Cardioprotection against ischaemia induced by dobutamine stress using glucagon-like peptide-1 in patients with coronary artery disease JO - Heart VL - 98 UR - https://doi.org/10.1136/hrt.2010.219345 DO - 10.1136/hrt.2010.219345 ID - Read2012 ER - TY - JOUR AU - Chiquette, E. AU - Toth, P. P. AU - Ramirez, G. AU - Cobble, M. AU - Chilton, R. PY - 2012 DA - 2012// TI - Treatment with exenatide once weekly or twice daily for 30 weeks is associated with changes in several cardiovascular risk markers JO - Vasc Health Risk Manag VL - 8 ID - Chiquette2012 ER -